(Q45330725)

English

Autologous stem cell transplantation for follicular lymphoma is of most benefit early in the disease course and can result in durable remissions, irrespective of prior rituximab exposure

scientific article published on 18 January 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

13 December 2017

Autologous stem cell transplantation for follicular lymphoma is of most benefit early in the disease course and can result in durable remissions, irrespective of prior rituximab exposure (English)

1 reference

Europe PubMed Central

13 December 2017

follicular lymphoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Kirit M. Ardeshna

10

object named as

Kirit M Ardeshna

1 reference

Europe PubMed Central

13 December 2017

9

object named as

David C Linch

1 reference

Europe PubMed Central

13 December 2017

Anthony H. Goldstone

8

object named as

Anthony H Goldstone

1 reference

Europe PubMed Central

13 December 2017

5

object named as

Emma Morris

1 reference

Europe PubMed Central

13 December 2017

2

object named as

Karl S Peggs

1 reference

Europe PubMed Central

13 December 2017

4

object named as

Kirsty J Thomson

1 reference

Europe PubMed Central

13 December 2017

Jonathan P Lambert

7

object named as

Jonathan Lambert

1 reference

Europe PubMed Central

13 December 2017

author name string

Jaimal Kothari

1

1 reference

Europe PubMed Central

13 December 2017

Antonia Bird

3

1 reference

Europe PubMed Central

13 December 2017

Andres E Virchis

6

1 reference

Europe PubMed Central

13 December 2017

language of work or name

0 references

publication date

18 January 2014

1 reference

Europe PubMed Central

13 December 2017

British Journal of Haematology

1 reference

Europe PubMed Central

13 December 2017

165

1 reference

Europe PubMed Central

13 December 2017

3

1 reference

Europe PubMed Central

13 December 2017

334-340

1 reference

Europe PubMed Central

13 December 2017

Autologous stem cell transplantation in follicular lymphoma: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12741

21 January 2018

Treatment-related myelodysplasia and acute leukemia in non-Hodgkin's lymphoma patients

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12741

21 January 2018

Marrow-ablative treatment and autologous stem cell transplantation in follicular NHL.

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12741

21 January 2018

High-dose therapy followed by autologous purged stem-cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by GOELAMS.

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12741

21 January 2018

Stem cell transplantation for follicular lymphoma relapsed/refractory after prior rituximab: a comprehensive analysis from the NCCN lymphoma outcomes project.

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12741

21 January 2018

Follicular lymphoma: 2011 update on diagnosis and management

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12741

21 January 2018

Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12741

21 January 2018

Characteristics of relapse after autologous stem-cell transplantation for follicular lymphoma: a long-term follow-up.

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12741

21 January 2018

Impact of the use of autologous stem cell transplantation at first relapse both in naive and previously rituximab exposed follicular lymphoma patients treated in the GELA/GOELAMS FL2000 study.

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12741

21 January 2018

Myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission prolongs progression-free survival in follicular lymphoma: results of a prospective, randomized trial of the German Low-Grade Lymphoma Study Group

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12741

21 January 2018

Moderate increase of secondary hematologic malignancies after myeloablative radiochemotherapy and autologous stem-cell transplantation in patients with indolent lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Stu

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12741

21 January 2018

Long-term clinical and molecular remissions in patients with follicular lymphoma following high-dose therapy and autologous stem cell transplantation

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12741

21 January 2018

Myeloablative chemotherapy for chemo-sensitive recurrent follicular lymphoma: potential benefit in second relapse

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12741

21 January 2018

Durable event-free survival following autologous stem cell transplant for relapsed or refractory follicular lymphoma: positive impact of recent rituximab exposure and low-risk Follicular Lymphoma International Prognostic Index score.

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12741

21 January 2018

Rituximab purging and/or maintenance in patients undergoing autologous transplantation for relapsed follicular lymphoma: a prospective randomized trial from the lymphoma working party of the European group for blood and marrow transplantation.

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12741

21 January 2018

High-dose therapy improves progression-free survival and survival in relapsed follicular non-Hodgkin's lymphoma: results from the randomized European CUP trial

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12741

21 January 2018

T-cell-depleted reduced-intensity transplantation followed by donor leukocyte infusions to promote graft-versus-lymphoma activity results in excellent long-term survival in patients with multiply relapsed follicular lymphoma

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12741

21 January 2018

Autologous versus reduced-intensity allogeneic hematopoietic cell transplantation for patients with chemosensitive follicular non-Hodgkin lymphoma beyond first complete response or first partial response

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12741

21 January 2018

Long-term outcomes of autologous stem cell transplantation for follicular non-Hodgkin lymphoma: effect of histological grade and Follicular International Prognostic Index.

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12741

21 January 2018

Identifiers

10.1111/BJH.12741

1 reference

Europe PubMed Central

13 December 2017

1 reference

Europe PubMed Central

13 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45330725&oldid=2123623481"